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ABSTRACT 
This study was designed to compare the success of patients with ocular hypertension, secondary to pars plana vitrectomy 
and silicone oil tamponade, who received an Ex-PRESS Glaucoma Filtration Device P50 (Alcon Laboratories, Inc. Fort Worth, 
Texas, USA) to those who had conventional trabeculectomy. The records of 10 eyes of 10 consecutive subjects who had Ex-
press implants and 9 eyes of 9 consecutive controls who had trabeculectomy procedures were reviewed. Success was 
defined as the reduction of intraocular pressure (IOP) in patients who did not require further glaucoma surgery in the eye of 
note during the entire follow-up. IOP was reduced by 10.3 ± 9.7 mmHg (range -31 to 3) in the Ex-PRESS group and by 13.9 ± 
11.4 mmHg (range -35 to -4) in the trabeculectomy group. The difference in the percentage of IOP reduction between the 
standard trabeculectomy group (42.7%) and the Ex-PRESS group (35.9%) was not statistically significant (P = 0.72). The Ex-
PRESS device seems to be at least as effective as the standard trabeculectomy in lowering the IOP of patients with 
hypertension secondary to pars plana vitrectomy and silicone oil tamponade. Even though the data suggested that the Ex-
PRESS device did not result in an overall greater reduction in IOP than trabeculectomy, this does not reach statistical 
significance. 
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INTRODUCTION 
Silicone oil tamponade represents an important 
procedure in vitreoretinal surgery, especially in cases of 
complicated retinal detachments (1). Intraocular silicone 
oil is associated with several complications (keratopathy, 
cataract, glaucoma, subretinal migration of silicone oil 
droplet, proliferation of retinal fibrous membranes) if left 
in the vitreous cavity for an extended period of time (2, 
3). Increased intraocular pressure (IOP) is a rather 
common complication in eyes that have undergone pars 
plana vitrectomy with a silicone oil tamponade. 
Numerous studies have reported several risk factors for 
an increased IOP after silicone oil injections (4-10). Even 
if the uncontrolled IOP, which was induced by silicone oil 
tamponade, was not associated with a history of 
glaucoma (11), eyes with pre-existing uncontrolled ocular 
pressure were more likely to have postoperative 
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pressure complications (12).
 
It could be related to an 
acute pupillary block, choroidal effusions with anterior 
displacement of the lens–iris complex, anterior 
synechiae, and the migration of the emulsified oil in the 
anterior chamber (4-10), Glaucoma treatments are 
directed to balance IOP (13, 14),
 
either pharmacologically 
or surgically. Surgery is suggested when pharmacological 
strategies fail to control IOP (15).
 
Trabeculectomy is a 
conventional surgical approach (16). An alternative 
method could be to implant the Ex-PRESS® P50 glaucoma 
filtration device (Alcon Inc., Fort Worth, TX). This is a 
metallic, non-valved flow-restricting device, designed to 
reduce IOP in glaucomatous disorders (17).
 
It was 
proposed as a mini-invasive surgical filtering device (18, 
19), inserted under a costumed scleral flap to shunt 
aqueous humour from the anterior chamber to the 
filtration bleb (20).
 
During the surgical filtering 
procedures in vitrectomized eyes, the Ex-press device 
could offer better compliance than regular 
trabeculectomy, preventing unpredictable volume 
changes of the anterior and posterior chambers. In this 
study we compared the success of patients with ocular 
hypertension, secondary to silicone oil tamponade, who 
had an Ex-PRESS® P50 mini glaucoma shunt device 
implantation to those who had conventional 
trabeculectomy.  
MATERIALS AND METHODS 
Statement of Ethics: We certify that all applicable 
institutional and governmental regulations concerning 
the ethical use of human data were followed during this 
research. The analysis involves data from a retrospective 
cohort study. Patients were recruited at a single center 
(Policlinico di Bari, A. Moro University of Bari, 
Ophthalmology Department, Italy) between January 
2007 and November 2012. All patients underwent 23G 
pars plana vitrectomy and 1000 centistokes silicone oil 
tamponade. None of them were affected by glaucoma 
previous of retinal surgery. One surgeon (FC) performed 
all the surgeries for glaucoma. All surgeries were 
performed under local anesthesia (5 mL solution of 2.5 
mL of 2% lidocaine [xylocaine] and 2.5 mL of 0.5% 
bupivicaine [Marcaine]). Eyes treated with Ex-PRESS were 
implanted with the Ex-PRESS® P50 device under a scleral 
flap. The surgical procedures were similar in both 
treatment arms. A limbus-based conjunctival flap was 
dissected, followed by a “4 × 4 mm × half the scleral 
thickness” scleral flap dissected up to the cornea. A 
cellulose microsponge soaked in 0.4 mg/mL Mitomycin-C 
solution was applied to the scleral flap, with the 
conjunctive draped over the sponge for 3 minutes. The 
sponge was then removed and the area was washed with 
irrigating saline solution. For the eyes treated with EX-
PRESS® P50, the mini-implant was inserted parallel to the 
iris, through the “gray line” in the clear cornea. In the 
eyes treated with trabeculectomy, a sclerotomy 
associated with a peripheral iridectomy was performed. 
For both procedures the scleral flap was then sutured 
using two 10-0 nylon sutures at the edge of the flap. The 
conjunctiva was sutured over the limbus with one 
uninterrupted, single-running Vicryl suture. During the six 
postoperative weeks, topical corticosteroids and 
antibiotics were administered four times a day, along 
with 1% atropine, twice daily. All patients were aged 18 
years or older and all presented with ocular hypertension 
secondary to silicone oil tamponade, not controlled by 
medical therapy. Patients with myopia greater than -6 
diopters (D) or previous ocular filtrating glaucoma 
surgery were excluded. Optical assessments during the 
follow-up included applanation tonometry (21),
 
to 
measure IOP and the Early Treatment Diabetic 
Retinopathy Study chart for visual acuity (VA) (22).
 
Responses were classified as: intraocular pressure values 
less than 21 mmHg thresholds; no subsequent 
intraocular pressure medication prescribed; and no 
further surgery performed for ocular hypertension. 
Statistical analysis (analysis of variance, P < 0.5) was 
performed using InStat (GraphPad Software Inc, La Jolla, 
CA, USA). 
RESULTS 
The Ex-press group was comprised of 10 eyes of 10 
patients (8 men) with a mean age of 52.5 ± 13 years. Only 
three were affect by myopia (mean spherical equivalent: 
-2.75 ± 1.27 D). Lens phacoemulsification and intraocular 
lens implant were associated with 23G pars plana 
vitrectomy in 7 eyes. Ocular hypertension developed 9.2 
± 14.4 months (range = 1-49.5) after vitreoretinal 
surgery, EX-PRESS® P50 implant was performed 12.1 ± 
14.8 months (range = 0.7-38.8) later. The pre-operative 
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visual acuity and IOP were 1 ± 0.8 logMAR (range 0-2) 
and 26.2 ± 7.4 mmHg (range = 18-45). After 18.8 ± 14.3 
months (range=5.5-43.8), visual acuity and IOP were 0.83 
± 0.7 logMAR (range 0-2) and 15.9 ± 5.8 mmHg (range 12-
28), respectively. IOP was reduced by 35.9% (10.3 ± 9.7 
mmHg; range -31 to 3). 
The trabeculectomy group was comprised of 9 eyes of 9 
patients (6 women) with a mean age of 54.3 ± 16.8 years. 
Only four were myopic (mean spherical equivalent: -3.25 
± 1.34 D). Lens phacoemulsification and IOL implant were 
associated with 23G pars plana vitrectomy in 7 eyes. 
Ocular hypertension developed 44.9 ± 86.5 months 
(range 2-252.7) after retinal surgery. Medical 
hypotensive therapy was unsatisfactory after 5.6 ± 9.5 
months (range 0.03-30.2) and those eyes were scheduled 
for filtrating surgery. Pre-operative visual acuity and IOP 
were 1.1 ± 0.7 logMAR (range 0.4-2) and 28.9 ± 11.1 
(range 14-50). After 11.1 ± 10.8 months (range 3.9-39.3) 
visual acuity and IOP were 1.5 ± 0.9 logMAR (range 0.8-3) 
and 15 ± 4.7 (range 10-18), respectively. IOP was reduced 
by 42.7% (10 13.9 ± 11.4; range -35 to -4). In both groups, 
subsequent intraocular pressure medication was 
prescribed and further surgery was performed for ocular 
hypertension. Pre-operative IOP and visual acuity were 
similar in both groups (IOP: P = 0.54, VA: P = 0.27). After 
approximately one year, IOP reduced by 35.9% in the EX-
Press group and by 42.7% in the trabeculectomy group 
(Figure 1). Visual acuity was preserved in both groups 
(Ex-Press: P = 0.34, Trabeculectomy: P = 0.3) (Figure 2). 
Any significant differences were registered between the 
groups (IOP: P = 0.72, VA: P = 0.08). 
 
Figure 1. After approximately one year, IOP was reduced in the EX-Press and trabeculectomy groups, without any significant differences 
between them (P = 0.72) 
 
Figure 2. After one year of follow-up, visual acuity worsened, but not significantly (P = 0.08) in the trabeculectomy group 
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DISCUSSION
Many clinical and experimental studies have emphasized 
the role of silicone oil in the development of high 
intraocular pressure in vitrectomized eyes. Mechanisms 
include acute pupillary block, choroidal effusions with 
anterior displacement of the lens–iris complex, anterior 
synechiae, and emulsified silicone oil droplet in the 
anterior chamber (4-10, 23).
 
Electron microscopy showed 
that the emulsified silicone oil leaves the anterior 
chamber through the trabecular and uveoscleral routes 
(24). In eyes implanted with Ex-PRESS® P50, slit lamp 
biomicroscopy of the anterior segment did not reveal any 
silicone oil droplets under the surgical bleb. We believe 
the lumen of the device does not allow any silicone flow 
from anterior chamber to the conjunctival bleb. A study 
conducted on silicone oil emulsification demonstrated 
that the size of an oil droplet in the human anterior 
chamber was 0.038 ± 0.018 mm (25), which was 
considerably larger than the 50µ lumen of the device. 
Those assumptions suggest that the Ex-press device 
could not be blocked by silicone oil and no oil droplets 
could be leaked into the surgical bleb, allowing for a 
competent filtration. In our first case, even if both 
surgical procedures were effective at reducing ocular 
hypertension, the IOP was 3.6 mmHg higher in the 
trabeculectomy group (11.1 ± 10.8 months, range 3.9-
39.3) than in the Ex-PRESS group (18.8 ± 14.3 months, 
range 5.5-43.8). This could be related to an anomalous 
fibrotic proliferation of the bleb induced by higher stress 
during the surgical procedures on the anterior chamber 
during trabeculectomy. 
Any surgical approach on vitrectomized eyes has to 
preserve the anterior and posterior chambers in order to 
avoid hypotony and its complications of retinal 
detachment, choroidal hemorrhage, and choroidal 
effusion (26, 27). Some authors showed that there was a 
lower incidence of hypotony with the Ex-PRESS implant 
compared to trabeculectomy (17, 28). We did not record 
any complications with either technique, but we prefer 
the Ex-PRESS technique because of the lower incidence 
of hypotony, which is due to the reduced flow rate 
through the 50 lumen of the shunt (29). Developments in 
ophthalmic surgery have been focused on smaller 
incisions. The Ahmed glaucoma valve could be 
recommended to manage silicone oil ocular hypertension 
(30), but mini invasive techniques, such as the EX-PRESS 
shunt, seem more reliable. The present report is the first 
one-year long comparison of the efficacy of a 
trabeculectomy compared to the Ex-PRESS® P50 
glaucoma filtration device, based on a retrospective 
analysis of patients with ocular hypertension secondary 
to pars plana vitrectomy and silicone oil tamponade. We 
found that the Ex-PRESS implant could properly manage 
ocular hypertension induced by silicone oil tamponade 
and improved patient outcomes and visual recovery. 
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